Synergies, partnership outcomes, and lessons learned: a qualitative evaluation of cancer center-coalition engagement
- PMID: 40205614
- PMCID: PMC12091108
- DOI: 10.1093/jncics/pkaf038
Synergies, partnership outcomes, and lessons learned: a qualitative evaluation of cancer center-coalition engagement
Abstract
Background: Nine National Cancer Institute-Designated Cancer Centers received supplemental funding to expand community outreach and engagement activities through a partnership with Centers for Disease Control and Prevention-funded comprehensive cancer control coalitions. This article reports on an evaluation of these awards focused on organizational relationships and partnership outcomes.
Methods: The National Cancer Institute, community outreach and engagement, and coalition representatives co-designed the evaluation, which involved document review and 18 semistructured interviews with 16 community outreach and engagement and 19 coalition representatives. Artificial intelligence-generated interview transcripts were dual-coded in NVivo, version 20/R1, software.
Results: The funding generated a diverse collection of projects and partnerships. Community outreach and engagement-coalition synergies and lessons learned were evident in the following domains: infrastructure; community and partner engagement; data monitoring; and intervention implementation, evaluation, and dissemination. Outcomes of this funding initiative were evident in the following domains: strengthened partnerships, expanded knowledge, improved health or health-care programs and policies, and thriving communities.
Conclusions: Fostering community outreach and engagement-coalition partnerships created opportunities to use synergies and build capacity for engagement across multiple domains, contributing to enhanced trust and implementation of interventions across the cancer continuum. The findings provide examples and lessons on which cancer centers and coalitions can capitalize. Successful collaborative relationships were based on identifying shared goals and complementary expertise and roles, sharing financial and other resources, and a commitment to authentic and open dialogue. Although modest and short term, supplemental funding can strengthen organizational relationships and promote effective collaboration on community-facing activities; it can also lead to improved research engagement and translation of evidence to practice.
Published by Oxford University Press 2025.
Conflict of interest statement
A.V. is an employee of the NCI and was involved in administering the funding opportunity under evaluation. J.B.D., E.B., K.B., A.B., C.D., S.C., B.D., S.J., K.K., Je.L., Ja.L., J.A.M., M.P., L.P., K.W.S., H.T., M.W., and S.B.W. participated as grantees for the funding opportunity under evaluation. The authors declare no other competing interests.
Figures
 
              
              
              
              
                
                
                References
- 
    - Department of Health and Human Services. PAR-17-095 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30). Accessed October 4, 2023. https://grants.nih.gov/grants/guide/pa-files/PAR-17-095.html.
 
- 
    - Paskett ED, Hiatt RA. Catchment areas and community outreach and engagement: the new mandate for NCI-Designated Cancer Centers. Cancer Epidemiol Biomarkers Prev. 2018;27:517-519. - PubMed
 
- 
    - Department of Health and Human Services. PAR-21-321 Cancer Center Support Grants (CCSGs) for NCI-designated cancer centers (P30 clinical trial optional). Accessed October 4, 2023. https://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html
 
- 
    - Hiatt RA, Kobetz EN, Paskett ED. Catchment areas, community outreach and engagement revisited: the 2021 guidelines for Cancer Center Support Grants from the National Cancer Institute. Cancer Prev Res (Phila). 2022;15:349-354. - PubMed
 
MeSH terms
Grants and funding
- P30 CA015704/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- P30 CA046934/CA/NCI NIH HHS/United States
- 3P30CA091842-20S3, 3P30CA023108-42S3, 3P30CA015704-46S6, 3P30CA042014-32S5, 3P30CA069533-23S4, 3P30CA046934-32S5, 3P30CA022453-39S3, 3P30CA086862-21S5, 3P30CA016086-45S4, and 3P30CA022453-39S2/CA/NCI NIH HHS/United States
- P30 CA091842/CA/NCI NIH HHS/United States
LinkOut - more resources
- Full Text Sources
- Medical
